UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008085 |
|---|---|
| Receipt number | R000009512 |
| Scientific Title | A Phase II study of Neoadjuvant chemotherapy in Tri-weekly nab-Paclitaxel followed by FEC with Operable HER2 Negative breast cancer |
| Date of disclosure of the study information | 2012/06/01 |
| Last modified on | 2019/03/22 16:15:12 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/06/01 23:34:28 | ||
| 2 | Update | 2012/06/02 13:07:49 | Public title |
|
| 3 | Update | 2012/06/02 13:30:19 | Public title |
|
| 4 | Update | 2012/06/08 17:52:43 | Last name of contact person Last name of contact person |
|
| 5 | Update | 2012/06/08 17:55:07 | Interventions/Control_1 |
|
| 6 | Update | 2012/10/02 20:35:57 | Public title |
|
| 7 | Update | 2012/10/02 20:44:15 | Last name of contact person Last name of contact person Address Address TEL Organization Organization Category of Funding Organization |
|
| 8 | Update | 2013/12/05 22:07:13 | Recruitment status Last follow-up date |
|
| 9 | Update | 2014/06/01 12:48:28 | TEL |
|
| 10 | Update | 2019/03/22 16:15:12 | Recruitment status Date of IRB Last follow-up date |
